serine/threonine Kinase 17a (STK17A) Peptid
STK17A
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle STK17A Produkte
- STK17A (serine/threonine Kinase 17a (STK17A))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-STK17A antibody (Catalog #: AVARP02028_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- STK17A (serine/threonine Kinase 17a (STK17A))
- Hintergrund
-
STK17A belongs to the protein kinase superfamily, CAMK Ser/Thr protein kinase family, DAP kinase subfamily. It contains 1 protein kinase domain. STK17A acts as a positive regulator of apoptosis.This gene is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity.
Alias Symbols: DRAK1
Protein Interaction Partner: STK17A,STK17A
Protein Size: 414 - Molekulargewicht
- 46 kDa
- Gen-ID
- 9263
- NCBI Accession
- NM_004760, NP_004751
- UniProt
- Q9UEE5
-
Sie sind hier:
